# FDA Inspection 1202671 - UFAG Laboratorien AG - March 14, 2023

Source: https://www.keypedia.com/records/fda_inspections/ufag-laboratorien-ag/a5d5312b-d939-42ea-a9b5-39cc999ffa8c
Source feed: FDA_Inspections

> FDA Inspection 1202671 for UFAG Laboratorien AG on March 14, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1202671
- Company Name: UFAG Laboratorien AG
- Inspection Date: 2023-03-14
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1068822 - 2018-09-18](https://www.keypedia.com/records/fda_inspections/ufag-laboratorien-ag/6d1a9d25-adbd-4eb7-9f96-c9f97ff732d6)
- [FDA Inspection 906652 - 2014-12-05](https://www.keypedia.com/records/fda_inspections/ufag-laboratorien-ag/877d48ff-52ad-42ff-b324-78de7ff0788e)
- [FDA Inspection 771511 - 2012-03-08](https://www.keypedia.com/records/fda_inspections/ufag-laboratorien-ag/28e8aa9a-2980-4f17-ae02-b4143011fa94)

Company: https://www.keypedia.com/companies/ufag-laboratorien-ag/93342d96-9cf8-4c5f-9248-11d77990b790

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c